Worldwide Pain Therapeutics 2021 Industry Report - Key Opportunities and Challenges
23 juin 2021 08h03 HE
|
Research and Markets
Dublin, June 23, 2021 (GLOBE NEWSWIRE) -- The "Global Pain Therapeutics Market - Comprehensive Overview of Marketed and Pipeline Products, Opportunities, Challenges, Market Size and Key Players"...
Global Topical Pain Relief Market (2020 to 2025) - Featuring Advacare Pharma, Endo International & Grunenthal Among Others
16 avr. 2021 06h13 HE
|
Research and Markets
Dublin, April 16, 2021 (GLOBE NEWSWIRE) -- The "Topical Pain Relief Market" report has been added to ResearchAndMarkets.com's offering. This report is designed to be a helpful business tool that...
Global Migraine Drugs Market to 2025: Growing Demand for Electrical Nerve Stimulating Devices to Treat Migraine
15 déc. 2020 05h08 HE
|
Research and Markets
Dublin, Dec. 15, 2020 (GLOBE NEWSWIRE) -- The "Migraine Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been added to...
Worldwide Industry for Pain Management Drugs to 2027 - Advancements in Drug Development Presents Opportunities
08 oct. 2020 05h09 HE
|
Research and Markets
Dublin, Oct. 08, 2020 (GLOBE NEWSWIRE) -- The "Pain Management Drugs Market by Drug Class and Indication: Global Opportunity Analysis and Industry Forecast, 2019-2027" report has been added to...
DRGT Completes a Pivotal Phase I Trial; Results Confirm 6X Faster Attainment Of Maximum Plasma Levels For Pain Management Compared To Currently Available COX-2 Inhibitor
10 juin 2019 09h00 HE
|
Druggability Technologies Holdings Ltd
BUDAPEST, Hungary, June 10, 2019 (GLOBE NEWSWIRE) -- Druggability Technologies Holdings (DRGT) today announced results from a pharmacokinetic study of their novel formulation of celecoxib...
![American Heart Association Logo](/news-release/logo/213500/0/213500.jpg?lastModified=12%2F09%2F2016%2022%3A55%3A27&size=2)
Taking Painkillers Increases Death Risk, Second Heart Attacks in Survivors
10 sept. 2012 16h00 HE
|
American Heart Association
Study Highlights:
Heart attack survivors using common painkillers such as ibuprofen face a higher long-term risk of death or second heart attack.
The higher risk persists for at least five...